| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 81,247 | 97,865 | | Cost of Revenue | 8,127 | 122,417 | | | Gross Profit | 73,119 | (24,552) | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 80,848 | 80,459 | | Non Recurring |
-
|
-
| | Others | 5,640 | 1,214 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (13,368) | (106,225) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,896) |
-
| | Earnings Before Interest And Taxes | (16,264) | (106,225) | | Interest Expense | 581 | 1,055 | | Income Before Tax | (16,846) | (107,280) | | Income Tax Expense | (5,701) | (2,537) | | Minority Interest | 498 | (414) | | | | Net Income From Continuing Ops | (10,646) | (105,158) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (10,646) | (105,158) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($10,646) | ($105,158) |
|
0.22% Nasdaq 
Income Statement
